← Retour au Screener

Sector: Santé
Open in Terminal → TECN.SWLive chart · Key metrics · News · Smart money

Tecan Group

TECN.SW Mid Cap

Healthcare · Medical Instruments & Supplies

Mis à jour: Aug 2, 2026, 22:14 UTC

186,10 CHF
-0.43% aujourd'hui
52W: 110,60 CHF – 191,90 CHF
52W Low: 110,60 CHF Position: 92.9% 52W High: 191,90 CHF

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
24.49x
P/E prévisionnel
P/S Ratio
2.67x
Cours/Ventes
EV/EBITDA
27.69x
Valeur d'entreprise/EBITDA
Rend. dividende
1.61%
Rendement annuel du dividende
Cap. boursière
2,0 Md €
Capitalisation boursière
Croissance du CA
-5.2%
Croissance du CA sur un an
Marge bénéficiaire
-12.54%
Marge nette
ROE
-8.55%
Rentabilité des capitaux propres
Beta
1.07
Sensibilité au marché
Positions vendeuses
% du flottant vendu à découvert
Volume moyen
51,992
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
8 analysts
Avg. Price Target
175,47 CHF
-5.71% upside
Target Range
142,00 CHF – 220,00 CHF

About the Company

Sector: Healthcare Industry: Medical Instruments & Supplies Country: Switzerland Employees: 3,026 Exchange: EBS

Tecan Group en bref

Tecan Group (TECN.SW) is currently trading at 186,10 CHF with a market capitalization of 2,0 Md €. The 52-week range spans from 110,60 CHF to 191,90 CHF ; the current price is 3% below the yearly high. Year-over-year revenue growth stands at -5.2%.

💰 Dividende

Tecan Group pays an annual dividend of 3,00 CHF per share, representing a yield of 1.61%. The payout ratio stands at 60.61%.

📊 Avis des analystes

8 analystes évaluent Tecan Group (TECN.SW) au consensus : Acheter. L'objectif de cours moyen est de 175,47 CHF , soit un potentiel de -5.71% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 142,00 CHF à 220,00 CHF .

Tecan Group : la thèse d'investissement en détail

Tecan Group (TECN.SW) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue is contracting at -5.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

Valorisation en contexte

The EV/EBITDA multiple of 27.69x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

À surveiller

  • The share is trading at 92.9% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Points forts
  • Consensus des analystes : Buy
  • Bilan solide avec faible endettement (D/E 18.96)
  • Free cash flow positif
Points faibles
  • CA en contraction (-5.2% sur un an)
  • Actuellement non rentable

Aperçu technique

MM 50 jours
166,21 CHF
+11.97% vs. cours
MM 200 jours
142,35 CHF
+30.73% vs. cours
Sous le plus haut 52s
−3%
191,90 CHF
Au-dessus du plus bas 52s
+68.3%
110,60 CHF

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
1.07 · Proche du marché
Évolue plus que le marché global
Dette/Capitaux propres
18.96 · Faible
Dette totale / capitaux propres

The data points to market-like volatility.

Trading Data

50-Day MA: 166,21 CHF
200-Day MA: 142,35 CHF
Volume: 45,841
Avg. Volume: 51,992
Short Ratio:
P/B Ratio: 2.03x
Debt/Equity: 18.96x
Free Cash Flow: 99 M €

💵 Dividend Info

Dividend Yield
1.61%
Annual Rate
3,00 CHF
Payout Ratio
60.61%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Tecan Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut